#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2594	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2617	227.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1731	1731	C	327	C	287	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2594	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2617	227.0	0	HET	.	.	.	C542T,A	.	542	542	C	1089	1089	C	312	C,T,A	202,54,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3997	230.7	0	.	n	.	0	T695C	SNP	695	695	T	1211	1211	C	286	C,A	243,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3997	230.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1853	1853	A	300	A,T	258,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3997	230.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2487	2487	C	244	C,A	222,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3997	230.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2561	2561	A	252	A,C	220,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3997	230.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3113	3113	C	276	C	245	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	332	folP	855	855	100.0	folP.l6.c4.ctg.1	1892	42.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1226	1228	AGC	58;58;59	A;G;C	52;52;53	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	676	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3716	42.2	1	SNP	p	S91F	1	.	.	271	273	TTC	671	673	TTC	57;59;59	T;T;C	42;43;44	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	676	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3716	42.2	1	SNP	p	D95G	1	.	.	283	285	GGC	683	685	GGC	58;58;58	G;G;C	45;44;42	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	676	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3716	42.2	1	SNP	p	G95N	0	.	.	283	285	GGC	683	685	GGC	58;58;58	G;G;C	45;44;42	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	240	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1700	33.0	1	SNP	p	G45D	1	.	.	133	135	GAC	584	586	GAC	54;56;56	G;A;C	45;44;45	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	150	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1457	24.0	0	.	n	.	0	A197.	DEL	197	197	A	807	807	A	63	A	54	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	670	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3524	44.9	1	SNP	p	D86N	1	D86N	NONSYN	256	258	GAC	882	884	AAC	45;45;45	A,G;A,C;C	27,1;34,1;40	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	670	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3524	44.9	1	SNP	p	S87R	0	.	.	259	261	AGT	885	887	AGT	45;46;46	A,C;G,T,C;T,G	39,1;37,1,1;35,5	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	670	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3524	44.9	1	SNP	p	S87W	0	.	.	259	261	AGT	885	887	AGT	45;46;46	A,C;G,T,C;T,G	39,1;37,1,1;35,5	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	670	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3524	44.9	1	SNP	p	S87I	0	.	.	259	261	AGT	885	887	AGT	45;46;46	A,C;G,T,C;T,G	39,1;37,1,1;35,5	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	670	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3524	44.9	1	SNP	p	S88P	0	.	.	262	264	TCC	888	890	TCC	46;47;44	T;C,T;C,A	38;41,1;40,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	636	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3235	46.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1796	1798	GGC	51;51;51	G;G;C,G	42;44;42,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1298	1300	GCA	63;63;63	G;C;A	59;58;57	penA.13.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1301	1303	ATC	63;63;63	A;T;C	58;59;58	penA.13.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1313	1315	GTG	65;65;65	G;T;G	61;59;60	penA.13.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1313	1315	GTG	65;65;65	G;T;G	61;59;60	penA.13.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1817	1819	ACC	38;38;36	A;C;C	29;28;31	penA.13.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1871	1873	GTG	27;26;26	G;T;G	25;25;23	penA.13.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1871	1873	GTG	27;26;26	G;T;G	25;25;23	penA.13.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1994	1996	GGC	29;29;31	G,T;G;C,T,A	27,1;28;27,1,1	penA.13.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2003	2005	GGC	30;30;30	G;G;C	26;23;18	penA.13.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	474	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2678	40.2	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2021	2023	TCG	31;31;31	T,G;C,A;G,C	19,2;24,1;25,1	penA.13.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	696	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3725	42.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1936	1938	CCG	53;53;53	C,T,G;C;G,C	40,2,1;45;35,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	336	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2229	35.6	0	.	p	.	0	A17T	NONSYN	49	51	GCA	586	588	ACA	26;26;26	A;C;A	24;22;23	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	336	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2229	35.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	601	603	GGC	24;24;24	G;G;C	22;22;22	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	336	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2229	35.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	783	783	C	19	C	14	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	718	720	GGA	62;62;62	G;G;A	60;58;58	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	T87A	NONSYN	259	261	ACT	835	837	GCT	70;69;68	G;C;T	64;64;59	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	T89S	NONSYN	265	267	ACC	841	843	AGC	67;67;67	A;G;C	62;63;62	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	1003	1005	CAA	73;73;73	C;A;A	67;66;66	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1027	1029	GCA	62;62;62	G;C;A	57;54;53	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	1135	1137	CAA	68;68;68	C;A;A	61;61;61	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	N189S	NONSYN	565	567	AAC	1141	1143	AGC	66;66;67	A;G;C	58;59;59	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	1210	1210	T	67	T	60	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	1	SNP	p	G120K	1	.	.	358	360	AAG	934	936	AAG	57;57;58	A,C;A;G	53,1;54;55	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	1	SNP	p	A121D	1	.	.	361	363	GAC	937	939	GAC	60;59;59	G;A;C	56;56;55	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	418	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2251	44.1	1	SNP	p	D121N	0	.	.	361	363	GAC	937	939	GAC	60;59;59	G;A;C	56;56;55	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1388	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5432	58.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2254	2256	AAT	69;69;69	A;A;T	59;59;59	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	206	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1404	35.5	1	SNP	p	V57M	1	.	.	169	171	ATG	698	700	ATG	71;70;70	A;T;G	65;66;66	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
